The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Abstract
Tissue inhibitors of metalloproteinases (TIMPs) are the major cellular inhibitors of the matrix metalloproteinase (MMP) sub-family, exhibiting varying efficacy against different members, as well as different tissue expression patterns and modes of regulation. Other proteins have modest inhibitory activity against some of the MMPs, including domains of netrins,the procollagen C-terminal proteinase enhancer (PCPE), the reversion-inducing cysteine-rich protein with Kazal motifs (RECK), and tissue factor pathway inhibitor (TFPI-2), but their physiological significance is not at all clear.α2-Macroglobulin, thrombospondin-1 and thrombospondin-2 can bind to some MMPs and act as agents for their removal from the extracellular environment. In contrast, few effective inhibitors of other members of the metzincin family, the astacins or the distintegrin metalloproteinases, ADAMs have been identified. Many of these MMP inhibitors, including the TIMPs, possess other biological activities which may not be related to their inhibitory capacities. These need to be thoroughly characterized in order to allow informed development of MMP inhibitors as potential therapeutic agents. Over activity of MMPs has been implicated in many diseases, including those of the cardiovascular system,arthritis and cancer. The development of synthetic small molecule inhibitors has been actively pursued for some time, but the concept of the use of the natural inhibitors, such as the TIMPs, in gene based therapies is being assessed in animal models and should provide useful insights into the cell biology of degradative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
ECM and Cell Surface Proteolysis: Regulating Cellular Ecology
Werb, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80429-8 · Cited by 1,307
Activation mechanisms of matrix metalloproteinases.
Nagase, H. (1997) · PubMed · Cited by 1,119
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Pyo, R., Lee, J. K., Shipley, J. M., Curci, J. A., Mao, D., Ziporin, S. J., Ennis, T. L., Shapiro, S. D., Senior, R. M., & Thompson, R. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8931 · Cited by 830
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., & Iwata, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80015-9 · Cited by 695
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
Self-citationCreemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E., & Reidy, M. A. (1994) · Circulation Research · doi:10.1161/01.res.75.3.539 · Cited by 584
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13221 · Cited by 492
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., & Edwards, D. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37115-6 · Cited by 480
Self-citationButler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M.-P., & Murphy, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.871 · Cited by 470
Self-citationBaker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Self-citationCell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
Hayakawa, T., Yamashita, K., Ohuchi, E., & Shinagawa, A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.9.2373 · Cited by 451
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Self-citationGuedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., & Stetler-Stevenson, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2881 · Cited by 397
TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo
Wang, Z., Juttermann, R., & Soloway, P. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001270200 · Cited by 390
Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.6.1723 · Cited by 338
TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix
Yu, W.-H., Yu, S.-S. C., Meng, Q., Brew, K., & Woessner, J. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000907200 · Cited by 328
Martignetti, J. A., Aqeel, A. A., Sewairi, W. A., Boumah, C. E., Kambouris, M., Mayouf, S. A., Sheth, K. V., Eid, W. A., Dowling, O., Harris, J., et al. (2001) · Nature Genetics · doi:10.1038/90100 · Cited by 312
α 2 -macroglobulin: an evolutionarily conserved arm of the innate immune system
Armstrong, P. B., & Quigley, J. P. (1999) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(99)00018-x · Cited by 305
Bendeck, M. P., Irvin, C., & Reidy, M. A. (1996) · Circulation Research · doi:10.1161/01.res.78.1.38 · Cited by 297
Baker, A. H., George, S. J., Zaltsman, A. B., Murphy, G., & Newby, A. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690217 · Cited by 286
Self-citationMolecular characterization and expression of the gene encoding human erythroid-potentiating activity
Gasson, J. C., Golde, D. W., Kaufman, S. E., Westbrook, C. A., Hewick, R. M., Kaufman, R. J., Wong, G. G., Temple, P. A., Leary, A. C., Brown, E. L., et al. (1985) · Nature · doi:10.1038/315768a0 · Cited by 273
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
Ahonen, M., Baker, A. H., & Kähäri, V. (1998) · PubMed · Cited by 266
Self-citationMarimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
Bramhall, S. R., Hallissey, M. T., Whiting, J., Scholefield, J., Tierney, G., Stuart, R. C., Hawkins, R. E., McCulloch, P., Maughan, T., Brown, P. D., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600310 · Cited by 265
Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery
Zempo, N., Kenagy, R. D., Au, Y. P. T., Bendeck, M., Clowes, M. M., Reidy, M. A., & Clowes, A. W. (1994) · Journal of Vascular Surgery · doi:10.1016/0741-5214(94)90008-6 · Cited by 261
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand‐Apte, B., Pepper, M. S., Voest, E. E., Montesano, R., Olsen, B. R., Murphy, G., Apte, S., & Zetter, B. R. (1997) · PubMed · Cited by 251
Self-citationLeco, K. J., Waterhouse, P. D., Sanchez, O. H., Gowing, K. L. M., Poole, A. R., Wakeham, A. C., Mak, T. W., & Khokha, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12067 · Cited by 246
Growth Stimulation of Human Keratinocytes by Tissue Inhibitor of Metalloproteinases
Bertaux, B., Hornebeck, W., Eisen, A. Z., & Dubertret, L. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483956 · Cited by 244
Herman, M. P., Sukhova, G. K., Kisiel, W., Foster, D., Kehry, M. R., Libby, P., & Schönbeck, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10403 · Cited by 236
Leco, K. J., Waterhouse, P., Sanchez, O. H., Gowing, K. L. M., Poole, A. R., Wakeham, A., Mak, T. W., & Khokha, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112067 · Cited by 230
Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., & Strickland, D. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100121200 · Cited by 222
George, S. J., Lloyd, C. T., Angelini, G. D., Newby, A. C., & Baker, A. H. (2000) · Circulation · doi:10.1161/01.cir.101.3.296 · Cited by 207
Self-citationGeorge, S. J., Johnson, J. L., Angelini, G. D., Newby, A. C., & Baker, A. H. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-867 · Cited by 198
Self-citationBányai, L., & Patthy, L. (1999) · Protein Science · doi:10.1110/ps.8.8.1636 · Cited by 193
Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activity
Stetler-Stevenson, W. G., Bersch, N., & Golde, D. W. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80386-u · Cited by 192
Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S. T., & Clowes, A. W. (1996) · Circulation Research · doi:10.1161/01.res.79.4.812 · Cited by 189
Smith, M. R., Kung, H.-F., Durum, S. K., Colburn, N. H., & Sun, Y. (1997) · Cytokine · doi:10.1006/cyto.1997.0233 · Cited by 188
Silence, J., Collen, D., & Lijnen, H. R. (2002) · Circulation Research · doi:10.1161/01.res.0000016501.56641.83 · Cited by 186
Corcoran, M. L., & Stetler-Stevenson, W. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13453 · Cited by 183
Accelerated apoptosis in the Timp-3–deficient mammary gland
Fata, J. E., Leco, K. J., Voura, E. B., Yu, H.-Y. E., Waterhouse, P., Murphy, G., Moorehead, R. A., & Khokha, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13171 · Cited by 183
Self-citationGrignon, D. J., Sakr, W., Tóth, M., Ravery, V. V., Angulo, J. C., Shamsa, F. H., Pontes, J. E., Crissman, J. C., & Fridman, R. (1996) · PubMed · Cited by 182
Chesler, L., Golde, D., Bersch, N., & Johnson, M. (1995) · Blood · doi:10.1182/blood.v86.12.4506.bloodjournal86124506 · Cited by 169
Ongoing trials with matrix metalloproteinase inhibitors
Brown, P. D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.9.2167 · Cited by 167
Rouis, M., Adamy, C., Duverger, N., Lesnik, P., Horellou, P., Moreau, M., Emmanuel, F., Caillaud, J. M., Laplaud, P. M., Dachet, C., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.533 · Cited by 165
Caterina, J. J., Yamada, S. S., Caterina, N. C. M., Longenecker, G., Holmbäck, K., Shi, J., Yermovsky-Kammerer, A. E., Engler, J. A., & Birkedal‐Hansen, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001271200 · Cited by 149
Bian, J., Wang, Y., Smith, M. R., Kim, H., Jacobs, C., Jackman, J., Kung, H., Colburn, N. H., & Sun, Y. (1996) · Carcinogenesis · doi:10.1093/carcin/17.9.1805 · Cited by 149
Bigg, H. F., Morrison, C., Butler, G. S., Bogoyevitch, M. A., Wang, Z., Soloway, P. D., & Overall, C. M. (2001) · PubMed · Cited by 144
George, S. J., Baker, A. H., Angelini, G. D., & Newby, A. C. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300764 · Cited by 143
Self-citationSouthgate, K. M., Fisher, M., BANNING, A. P., Thurston, V., Baker, A. H., Fabunmi, R. P., Groves, P. H., Davies, M., & Newby, A. C. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1177 · Cited by 142
Self-citationBond, M., Murphy, G., Bennett, M. R., Newby, A. C., & Baker, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111507200 · Cited by 140
Self-citationYang, T.-T., & Hawkes, S. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10676 · Cited by 137
Tóth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z., Bigg, H. F., Overall, C. M., DeClerck, Y. A., Tschesche, H., Cher, M. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006871200 · Cited by 136
The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth.
Edwards, D. R., Beaudry, P. P., Laing, T. D., Kowal, V. O., Leco, K. J., Leco, P. A., & Lim, M. S. (1996) · PubMed · Cited by 135
Self-citationGeorge, S. J., Zaltsman, A. B., & Newby, A. C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00211-8 · Cited by 126
DOLLERY, C. M., Humphries, S. E., McClelland, A., Latchman, D. S., & McEwan, J. R. (1999) · Circulation · doi:10.1161/01.cir.99.24.3199 · Cited by 125
Stetler‐Stevenson, M., Mansoor, A., Lim, M. S., Fukushima, P. I., Kehrl, J. H., Marti, G. E., Ptaszyński, K., Wang, J., & Stetler‐Stevenson, W. G. (1997) · Blood · doi:10.1182/blood.v89.5.1708 · Cited by 124
Barmina, O. Y., Walling, H. W., Fiacco, G. J., Freije, J. M. P., López-Otı́n, C., Jeffrey, J. J., & Partridge, N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30087 · Cited by 124
Vaillant, B. D., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7017 · Cited by 124
TIMP-1 Deficiency Does Not Attenuate Interstitial Fibrosis in Obstructive Nephropathy
Kim, H., Oda, T., López-Guisa, J. M., Wing, D., Edwards, D. R., Soloway, P. D., & Eddy, A. A. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v124736 · Cited by 121
Self-citationJiang, Y., Wang, M., Celiker, M., Liu, Y., Sang, Q., Goldberg, I. D., & Shi, Y. E. (2001) · PubMed · Cited by 119
Cheng, L., Mantile, G., Pauly, R. R., Nater, C., Felici, A., Monticone, R. E., Bilato, C., Gluzband, Y. A., Crow, M. T., Stetler‐Stevenson, W. G., et al. (1998) · Circulation · doi:10.1161/01.cir.98.20.2195 · Cited by 119
Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus
Bond, M., Murphy, G., Bennett, M. R., Amour, A., Knäuper, V., Newby, A. C., & Baker, A. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007929200 · Cited by 118
Self-citationMoestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Nykjær, A., Andreasen, P. A., Rasmussen, H. H., Sottrup‐Jensen, L., & Gliemann, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38702-2 · Cited by 117
de Smet, B. J. G. L., de Kleijn, D. P. V., Hanemaaijer, R., Verheijen, J. H., Robertus, L., van der Helm, Y. J. M., Borst, C., & Post, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.25.2962 · Cited by 109
Wingfield, P. T., Sax, J. K., Stahl, S. J., Kaufman, J. D., Palmer, I. W., Chung, V., Corcoran, M. L., Kleiner, D. E., & Stetler‐Stevenson, W. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21362 · Cited by 108
Brand, K., Baker, A. H., Pérez‐Canto, A., Possling, A., Sacharjat, M., Geheeb, M., & Arnold, W. (2000) · PubMed · Cited by 103
Self-citationRitter, L. M., Garfield, S. H., & Thorgeirsson, U. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0408 · Cited by 95
A phase II trial of marimastat in advanced pancreatic cancer
Evans, J. D., Stark, A., Johnson, C. D., Daniel, F., Carmichael, J., BUCKELS, J. A. C., IMRIE, C. W., Brown, P. D. N., & Neoptolemos, J. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2168 · Cited by 93
Southgate, K. M., Mehta, D., Izzat, M. B., Newby, A. C., & Angelini, G. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1640 · Cited by 86
Ae, K., Urbanski, S., & Edwards, D. R. (1991) · Blood · doi:10.1182/blood.v77.11.2475.2475 · Cited by 86
Self-citationNemeth, J. A., Rafe, A., Steiner, M., & Goolsby, C. L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0117 · Cited by 84
Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis
George, S. J. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00005 · Cited by 76
Ahonen, M., Ala‐aho, R., Baker, A. H., George, S. J., Grenman, R. A., Saarialho‐Kere, U., & Kähäri, V. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0606 · Cited by 71
Self-citationOelmann, E. M., Herbst, H., Zühlsdorf, M., Albrecht, O., Nolte, A., Schmitmann, C., Manzke, O., Diehl, V., Stein, H., & Berdel, W. E. (2002) · Blood · doi:10.1182/blood.v99.1.258 · Cited by 71
Celiker, M., Wang, M., Atsidaftos, E., Liu, X., Liu, Y., Jiang, Y., Valderrama, E., Goldberg, I. D., & Shi, Y. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204508 · Cited by 67
Godenschwege, T. A., Pohar, N., Buchner, S., & Buchner, E. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00072 · Cited by 57
Sobue, T., Hakeda, Y., Kobayashi, Y., Hayakawa, H., Yamashita, K., Aoki, T., Kumegawa, M., Noguchi, T., & Hayakawa, T. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.12.2205 · Cited by 57
Cherr, G. S., Motew, S. J., Travis, J. A., Fingerle, J., Fisher, L., Brandl, M., Williams, J. K., & Geary, R. L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101129 · Cited by 49
Models for Gain-of-Function and Loss-of-Function of MMPs: Transgenic and Gene Targeted Mice
Coussens, L. M., Shapiro, S. D., Soloway, P. D., & Werb, Z. (2003) · Humana Press eBooks · doi:10.1385/1-59259-046-2:149 · Cited by 31
Li, H., Nishio, K., Yamashita, K., Hayakawa, T., & Hoshino, T. (1995) · PubMed · doi:10.18999/nagjms.58.3-4.133 · Cited by 21
The Tissue Inhibitors of Metalloproteinases (TIMPs): Biology and Regulation
Edwards, D. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-011-x:67 · Cited by 11
Self-citation
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Self-citationMatrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Metadata
- Authors
- Baker, A. H., Edwards, D. R., & Murphy, G.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2002-10-01
- Volume
- 115
- Issue
- 19
- Pages
- 3719-3727
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2152487395
- Cited by
- 1,179
- References
- 90
- FWCI
- 22.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.